EBS - Emergent Biosolutions EPS beats by $0.70 beats on revenue February, 20 2020 04:37 PM Emergent Biosolutions Inc. Emergent Biosolutions (NYSE:EBS): Q4 Non-GAAP EPS of $1.57 beats by $0.70; GAAP EPS of $0.89 beats by $0.02.More news on: Emergent BioSolutions Inc., Earnings news and commentary, Healthcare stocks news, Read more ...